Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

Journal of Viral Hepatitis

Volumn 13, Issue 2, 2006, Pages 96-103

  Van Der Eijk, A A ^a   Niesters, H G M ^a   Hansen, B E ^a   Heijtink, R A ^a   Janssen, H L A ^a   Schalm, S W ^a   De Man, R A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

HBV DNA; Hepatitis B e antigen; Interferon; Predictive value

Indexed keywords

ALPHA INTERFERON; HEPATITIS B(E) ANTIGEN; PEGINTERFERON; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; GENETIC MARKERS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33645109452     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00661.x     Document Type: Article

References (17)

1. Liaw YF Leung N Guan R Lau GK Merican I Asian-Pacific consensus statement on the management of chronic hepatitis B: an update J Gastroenterol Hepatol 2003 18 3 239 245
2. Perrillo RP Schiff ER Davis GL et al A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group N Engl J Med 1990 323 5 295 301
3. Janssen HL Gerken G Carreno V et al Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP) Hepatology 1999 30 1 238 243
4. Wai CT Chu CJ Hussain M Lok AS HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C Hepatology 2002 36 6 1425 1430
5. Pas SD Fries E De Man RA Osterhaus AD Niesters HG Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays J Clin Microbiol 2000 38 8 2897 2901
6. Heijtink RA Janssen HL Hop WC Osterhaus AD Schalm SW Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy J Viral Hepat 2000 7 5 382 386
7. Perrillo R Mimms L Schechtman K Robbins D Campbell C Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing Hepatology 1993 18 6 1306 1312
8. Brouwer JT Hansen BE Niesters HG Schalm SW Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT J Hepatol 1999 30 2 192 198
9. Fried MW Shiffman ML Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 2002 347 13 975 982
10. National Institutes of Health Consensus Development Conference Statement Management of hepatitis C: 2002 - June 10-12, 2002 Hepatology 2002 36 5 Suppl. 1 3 20
11. Heijtink RA Kruining J Honkoop P et al. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B J Med Virol 1997 53 3 282 287
12. Heermann KH Gerlich WH Chudy M Schaefer S Thomssen R Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group J Clin Microbiol 1999 37 1 68 73
13. Stuyver L Van Geyt C De Gendt S et al Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy J Clin Microbiol 2000 38 2 702 707
14. Lok AS Heathcote EJ Hoofnagle JH Management of hepatitis b: 2000-summary of a workshop Gastroenterology 2001 120 7 1828 1853
15. DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988 44 3 837 845
16. van Nunen AB Hansen BE Suh DJ et al Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase Gut 2003 52 3 420 424
17. Lok AS Ghany MG Watson G Ayola B Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B J Viral Hepat 1998 5 3 171 178